H. Lundbeck A/S (CPH:HLUN.B)
40.02
-0.12 (-0.30%)
May 19, 2026, 11:12 AM CET
H. Lundbeck Revenue
H. Lundbeck had revenue of 7.13B DKK in the quarter ending March 31, 2026, with 14.27% growth. This brings the company's revenue in the last twelve months to 25.52B, up 11.19% year-over-year. In the year 2025, H. Lundbeck had annual revenue of 24.63B with 11.93% growth.
Revenue (ttm)
25.52B
Revenue Growth
+11.19%
P/S Ratio
1.52
Revenue / Employee
5.10M
Employees
5,039
Market Cap
38.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.63B | 2.63B | 11.93% |
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| Genmab | 25.29B |
| Demant | 22.97B |
| GN Store Nord | 16.60B |
| Zealand Pharma | 9.24B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
H. Lundbeck News
- 5 days ago - H. Lundbeck Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - H. Lundbeck Transcript: AGM 2026 - Transcripts
- 3 months ago - Lundbeck price target lowered to DKK 40 from DKK 44 at Deutsche Bank - TheFly
- 4 months ago - Lundbeck price target lowered to DKK 50 from DKK 53 at Barclays - TheFly
- 6 months ago - H. Lundbeck Transcript: Jefferies Global Healthcare Conference - Transcripts
- 6 months ago - H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - WSJ
- 6 months ago - H. Lundbeck Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - H. Lundbeck Earnings Call Transcript: Q2 2025 - Transcripts